左甲状腺素单药治疗的无甲状腺患者中反映甲状腺功能的生化标志物
该前瞻性研究纳入133例接受全甲状腺切除术的甲状腺乳头状癌患者,比较术前与术后12个月左甲状腺素治疗时的血清标志物。结果提示TSH轻度抑制(0.03<TSH≤0.3 μIU/mL)且fT3达术前水平的患者代谢标志物最接近术前状态,TSH正常者轻度甲减,TSH强烈抑制者轻度甲亢。
要点
- TSH强烈抑制(≤0.03 μIU/mL)者术后性激素结合球蛋白(p<0.001)和骨碱性磷酸酶(p<0.01)显著升高。
- TSH正常(0.3<TSH≤5 μIU/mL)者术后低密度脂蛋白胆固醇显著升高(p<0.05),酒石酸抵抗酸性磷酸酶5b显著降低(p<0.05)。
- TSH轻度抑制(0.03<TSH≤0.3 μIU/mL)且fT3达术前水平者,所有代谢标志物与术前相当。
核心结论
- 全甲状腺切除术后左甲状腺素治疗患者的血清生化标志物提示,TSH轻度抑制者最接近甲状腺功能正常,TSH正常者轻度甲减,TSH强烈抑制者轻度甲亢。
研究设计与样本
- 前瞻性研究,纳入133例接受全甲状腺切除术的甲状腺功能正常甲状腺乳头状癌患者,比较术前与术后12个月左甲状腺素治疗时的血清标志物。
主要发现
- TSH强烈抑制(≤0.03 μIU/mL)者术后性激素结合球蛋白(p<0.001)和骨碱性磷酸酶(p<0.01)显著升高。
- TSH正常(0.3<TSH≤5 μIU/mL)者术后低密度脂蛋白胆固醇显著升高(p<0.05),酒石酸抵抗酸性磷酸酶5b显著降低(p<0.05)。
- TSH轻度抑制(0.03<TSH≤0.3 μIU/mL)且fT3达术前水平者,所有代谢标志物与术前相当。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Some investigators reported that among athyreotic patients on levothyroxine (LT4) monotherapy following total thyroidectomy, the patients with normal serum thyrotropin (TSH) levels had mildly low serum free triiodothyronine (fT3) levels, whereas the patients with mildly suppressed serum TSH levels had normal serum fT3 levels, and the patients with strongly suppressed serum TSH had elevated serum fT3 levels. The objective of the present study was to clarify which of these three patient groups is closer to their preoperative euthyroid condition. METHODS: A total of 133 consecutive euthyroid patients with papillary thyroid carcinoma who underwent a total thyroidectomy were prospectively studied. The patients' serum levels of lipoproteins, sex hormone-binding globulin, and bone metabolic markers measured preoperatively were compared with the levels measured at postoperative LT4 therapy 12 months after the thyroidectomy. RESULTS: The postoperative serum sex hormone-binding globulin (p < 0.001) and bone alkaline phosphatase (p < 0.01) levels were significantly increased in the patients with strongly suppressed TSH levels (≤0.03 μIU/mL). The postoperative serum low-density lipoprotein cholesterol levels were significantly increased (p < 0.05), and the serum tartrate-resistant acid phosphatase-5b levels were significantly decreased (p < 0.05) in the patients with normal TSH (0.3 < TSH ≤5 μIU/mL). In the patients with mildly suppressed TSH (0.03 < TSH ≤0.3 μIU/mL) and fT3 levels equivalent to their preoperative levels, all metabolic markers remained equivalent to their preoperative levels. CONCLUSIONS: The serum biochemical markers of thyroid function in patients on LT4 following total thyroidectomy suggest that the patients with mildly suppressed TSH levels were closest to euthyroid, whereas those with normal TSH levels were mildly hypothyroid and those with strongly suppressed TSH levels were mildly hyperthyroid. These data may provide novel information on the management of patients following total thyroidectomy for thyroid cancer or benign thyroid disease.
引用
- Ito M, Miyauchi A, Hisakado M, et al. Biochemical Markers Reflecting Thyroid Function in Athyreotic Patients on Levothyroxine Monotherapy. Thyroid. 2017. PMID: 28056660. doi:10.1089/thy.2016.0426
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。